BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36005596)

  • 1. Weighted Gene Co-Expression Network Analysis and Support Vector Machine Learning in the Proteomic Profiling of Cerebrospinal Fluid from Extraventricular Drainage in Child Medulloblastoma.
    Bruschi M; Kajana X; Petretto A; Bartolucci M; Pavanello M; Ghiggeri GM; Panfoli I; Candiano G
    Metabolites; 2022 Aug; 12(8):. PubMed ID: 36005596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD).
    Bruschi M; Petretto A; Cama A; Pavanello M; Bartolucci M; Morana G; Ramenghi LA; Garré ML; Ghiggeri GM; Panfoli I; Candiano G
    Sci Rep; 2021 Jan; 11(1):1818. PubMed ID: 33469081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Profiling of Cerebrospinal Fluid and Its Extracellular Vesicles from Extraventricular Drainage in Pediatric Pilocytic Astrocytoma, towards Precision Oncology.
    Spinelli S; Kajana X; Garbarino A; Bartolucci M; Petretto A; Pavanello M; Verrina E; Candiano G; Panfoli I; Bruschi M
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
    Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
    BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Central Nervous System Oncologic Disease Biomarkers in EVs from Cerebrospinal Fluid (CSF) of Pediatric Patients: A Pilot Neuro-Proteomic Study.
    Kajana X; Spinelli S; Garbarino A; Balagura G; Bartolucci M; Petretto A; Pavanello M; Candiano G; Panfoli I; Bruschi M
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.
    Lee B; Mahmud I; Pokhrel R; Murad R; Yuan M; Stapleton S; Bettegowda C; Jallo G; Eberhart CG; Garrett T; Perera RJ
    Acta Neuropathol Commun; 2022 Feb; 10(1):25. PubMed ID: 35209946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary protein biomarkers for pediatric medulloblastoma.
    Hao X; Guo Z; Sun H; Liu X; Zhang Y; Zhang L; Sun W; Tian Y
    J Proteomics; 2020 Aug; 225():103832. PubMed ID: 32474013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic view of pediatric medulloblastoma proteomics-current state of the field and future directions.
    Serra R; Mangraviti A
    Childs Nerv Syst; 2021 Mar; 37(3):779-788. PubMed ID: 33409616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
    Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
    Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of cerebrospinal fluid from children with central nervous system tumors identifies candidate proteins relating to tumor metastatic spread.
    Spreafico F; Bongarzone I; Pizzamiglio S; Magni R; Taverna E; De Bortoli M; Ciniselli CM; Barzanò E; Biassoni V; Luchini A; Liotta LA; Zhou W; Signore M; Verderio P; Massimino M
    Oncotarget; 2017 Jul; 8(28):46177-46190. PubMed ID: 28526811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy.
    Tan N; Hu S; Hu Z; Wu Z; Wang B
    Mol Med Rep; 2020 Aug; 22(2):1257-1268. PubMed ID: 32468033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma.
    Lian H; Han YP; Zhang YC; Zhao Y; Yan S; Li QF; Wang BC; Wang JJ; Meng W; Yang J; Wang QH; Mao WW; Ma J
    Mol Oncol; 2019 Oct; 13(10):2227-2245. PubMed ID: 31385424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome and miRNome profiling of microvesicles derived from medulloblastoma cell lines with stem-like properties reveals biomarkers of poor prognosis.
    Kaid C; Assoni A; Marçola M; Semedo-Kuriki P; Bortolin RH; Carvalho VM; Okamoto OK
    Brain Res; 2020 Mar; 1730():146646. PubMed ID: 31917138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
    Macron C; Núñez Galindo A; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring genetic alterations in circulating tumor DNA from cerebrospinal fluid of pediatric medulloblastoma.
    Sun Y; Li M; Ren S; Liu Y; Zhang J; Li S; Gao W; Gong X; Liu J; Wang Y; Du S; Sun L; Wu W; Tian Y
    Sci Rep; 2021 Mar; 11(1):5638. PubMed ID: 33707557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury.
    Manek R; Moghieb A; Yang Z; Kumar D; Kobessiy F; Sarkis GA; Raghavan V; Wang KKW
    Mol Neurobiol; 2018 Jul; 55(7):6112-6128. PubMed ID: 29188495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of a Tumor-Promoting Microenvironment in Recurrent Medulloblastoma: A Multi-Omics Study of Cerebrospinal Fluid.
    Reichl B; Niederstaetter L; Boegl T; Neuditschko B; Bileck A; Gojo J; Buchberger W; Peyrl A; Gerner C
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic tests.
    Damiani D; Suciu V; Andreiuolo F; Calderaro J; Vielh P
    Cancer Cytopathol; 2015 Nov; 123(11):644-9. PubMed ID: 26769585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.